Knockdown of Aurora-B inhibits osteosarcoma cell invasion and migration via modulating PI3K/Akt/NF-κB signaling pathway

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 7, 2014, Pages 3984-3991

  Zhu, Liang Bo ^a   Jiang, Jian ^a,c   Zhu, Xiao Ping ^a   Wang, Tao Fang ^a   Chen, Xuan Yin ^a   Luo, Qin Feng ^b   Shu, Yong ^a   Liu, Zhi Li ^a   Huang, Shan Hu ^a  

^a NANCHANG UNIVERSITY   (China)

^b Cancer Hospital of Jiangxi Province   (China)

^c Department of Orthopedics People's Hospital of Shangrao City   (China)

Author keywords

Aurora B; Invasion and migration; Osteosarcoma; PI3K Akt NF B signaling pathway

Indexed keywords

AURKB PROTEIN, HUMAN; AURORA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

BONE TUMOR; CELL MOTION; GENE SILENCING; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; OSTEOSARCOMA; PATHOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR INVASION; WESTERN BLOTTING;

AURORA KINASE B; BLOTTING, WESTERN; BONE NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; GENE KNOCKDOWN TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASM INVASIVENESS; NF-KAPPA B; OSTEOSARCOMA; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

EID: 84906241841     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Laverdiere C, Hoang BH, Yang R, Sowers R, Qin J, Meyers PA, Huvos AG, Healey JH and Gorlick R. Messenger RNA expression levels of CXCR4 correlate with metastatic behavior and outcome in patients with osteosarcoma. Clin Cancer Res 2005; 11: 2561-2567.
2. Bacci G, Forni C, Longhi A, Ferrari S, Mercuri M, Bertoni F, Serra M, Briccoli A, Balladelli A and Picci P. Local recurrence and local control of non-metastatic osteosarcoma of the extremities: a 27-year experience in a single institution. J Surg Oncol 2007; 96: 118-123.
3. Jawad MU, Cheung MC, Clarke J, Koniaris LG and Scully SP. Osteosarcoma: improvement in survival limited to high-grade patients only. J Cancer Res Clin Oncol 2011; 137: 597-607.
4. Meyers PA, Schwartz CL, Krailo M, Kleinerman ES, Betcher D, Bernstein ML, Conrad E, Ferguson W, Gebhardt M, Goorin AM, Harris MB, Healey J, Huvos A, Link M, Montebello J, Nadel H, Nieder M, Sato J, Siegal G, Weiner M, Wells R, Wold L, Womer R and Grier H. Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol 2005; 23: 2004-2011.
5. Mialou V, Philip T, Kalifa C, Perol D, Gentet JC, Marec-Berard P, Pacquement H, Chastagner P, Defaschelles AS and Hartmann O. Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience. Cancer 2005; 104: 1100-1109.
6. Hegyi M, Semsei AF, Jakab Z, Antal I, Kiss J, Szendroi M, Csoka M and Kovacs G. Good prognosis of localized osteosarcoma in young patients treated with limb-salvage surgery and chemotherapy. Pediatr Blood Cancer 2011; 57: 415-422.
7. Stokkel MP, Linthorst MF, Borm JJ, Taminiau AH and Pauwels EK. A reassessment of bone scintigraphy and commonly tested pretreatment biochemical parameters in newly diagnosed osteosarcoma. J Cancer Res Clin Oncol 2002; 128: 393-399.
8. Guise TA, O'Keefe R, Randall RL and Terek RM. Molecular biology and therapeutics in musculoskeletal oncology. J Bone Joint Surg Am 2009; 91: 724-732.
9. Bonet C, Giuliano S, Ohanna M, Bille K, Allegra M, Lacour JP, Bahadoran P, Rocchi S, Ballotti R and Bertolotto C. Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells. J Biol Chem 2012; 287: 29887-29898.
10. Tuncel H, Shimamoto F, Kaneko Guangying Qi H, Aoki E, Jikihara H, Nakai S, Takata T and Tatsuka M. Nuclear Aurora B and cytoplasmic Survivin expression is involved in lymph node metastasis of colorectal cancer. Oncol Lett 2012; 3: 1109-1114.
11. Long ZJ, Xu J, Yan M, Zhang JG, Guan Z, Xu DZ, Wang XR, Yao J, Zheng FM, Chu GL, Cao JX, Zeng YX and Liu Q. ZM 447439 inhibition of aurora kinase induces Hep2 cancer cell apoptosis in three-dimensional culture. Cell Cycle 2008; 7: 1473-1479.
12. Zeng Q, Li S, Zhou Y, Ou W, Cai X, Zhang L, Huang W, Huang L and Wang Q. Interleukin-32 contributes to invasion and metastasis of primary lung adenocarcinoma via NF-kappaB induced matrix metalloproteinases 2 and 9 expression. Cytokine 2014; 65: 24-32.
13. Lee YD, Cui MN, Yoon HH, Kim HY, Oh IH and Lee JH. Down-modulation of Bis reduces the invasive ability of glioma cells induced by TPA through NF-kappaB mediated activation of MMP-9. BMB Rep 2014; 47: 262-7.
14. Liao CL, Lin JH, Lien JC, Hsu SC, Chueh FS, Yu CC, Wu PP, Huang YP, Lin JG and Chung JG. The crude extract of Corni Fructus inhibits the migration and invasion of U-2 OS human osteosarcoma cells through the inhibition of matrix metalloproteinase-2/-9 by MAPK signaling. Environ Toxicol 2013; [Epub ahead of print].
15. Campbell CS and Desai A. Tension sensing by Aurora B kinase is independent of survivin-based centromere localization. Nature 2013; 497: 118-121.
16. Bolanos-Garcia VM. Aurora kinases. Int J Biochem Cell Biol 2005; 37: 1572-1577.
17. Lee EC, Frolov A, Li R, Ayala G and Greenberg NM. Targeting Aurora kinases for the treatment of prostate cancer. Cancer Res 2006; 66: 4996-5002.
18. Chen BB, Glasser JR, Coon TA and Mallampalli RK. Skp-cullin-F box E3 ligase component FBXL2 ubiquitinates Aurora B to inhibit tumorigenesis. Cell Death Dis 2013; 4: e759.
19. Li J, Hu H, Lang Q, Zhang H, Huang Q, Wu Y and Yu L. A thienopyrimidine derivative induces growth inhibition and apoptosis in human cancer cell lines via inhibiting Aurora B kinase activity. Eur J Med Chem 2013; 65: 151-157.
20. Zhang T, Fields JZ, Opdenaker L, Otevrel T, Masuda E, Palazzo JP, Isenberg GA, Goldstein SD, Brand M and Boman BM. Survivin-induced Aurora-B kinase activation: A mechanism by which APC mutations contribute to increased mitoses during colon cancer development. Am J Pathol 2010; 177: 2816-2826.
21. Acosta KB, Tibolla MM, Tiscornia MM, Lorenzati MA and Zapata PD. Recent patents related to phosphorylation signaling pathway on cancer. Recent Pat DNA Gene Seq 2011; 5: 175-184.
22. Yao JE, Yan M, Guan Z, Pan CB, Xia LP, Li CX, Wang LH, Long ZJ, Zhao Y, Li MW, Zheng FM, Xu J, Lin DJ and Liu Q. Aurora-A down-regulates IkappaBalpha via Akt activation and interacts with insulin-like growth factor-1 induced phosphatidylinositol 3-kinase pathway for cancer cell survival. Mol Cancer 2009; 8: 95.